Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Bioorganic Chemistry|December 23, 2021
Synthesis, structure, properties and antimicrobial activity of para trifluoromethyl phenylboronic derivativesAgnieszka Adamczyk-Woźniak, Magdalena Tarkowska, Zofia Lazar, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|August 28, 2013
Intramolecular interactions in ortho-methoxyalkylphenylboronic acids and their catechol estersAgnieszka Adamczyk-Woźniak, Krzysztof M Borys, Karolina Czerwińska, et al.
Molecules (Basel, Switzerland)|February 16, 2020
5-Trifluoromethyl-2-formylphenylboronic AcidAgnieszka Adamczyk-Woźniak, Jan T Gozdalik, Dorota Wieczorek, et al.
Biomarkers in Medicine|February 11, 2016
Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastasesAgnieszka Adamczyk, Joanna Niemiec, Aleksandra Ambicka, et al.
Future Science OA|April 28, 2026
On the mode of anti-<i>C. albicans</i> activity of a bis(benzoxaborole) analogue of tavaboroleSachin Gadakh, Teresa Szczepińska, Małgorzata Potoczna, et al.
Anticancer Research|July 1, 2015
Prognostic Role of Nodal Status and Clinically Asymptomatic Valvular Insufficiency in Patients with HER2-positive Breast Cancer Treated with Chemotherapy, Radiotherapy and Trastuzumab in an Adjuvant SettingAleksandra Grela-Wojewoda, Joanna Niemiec, Beata Sas-Korczyńska, et al.
Cancers|September 10, 2021
Intra-Tumor Heterogeneity Revealed by Mass Spectrometry Imaging Is Associated with the Prognosis of Breast CancerMarta Gawin, Agata Kurczyk, Joanna Niemiec, et al.
Anticancer Research|March 31, 2018
Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast CarcinomasJoanna Niemiec, Agnieszka Adamczyk, Agnieszka Harazin-Lechowska, et al.
The Journal of Physical Chemistry. A|January 23, 2010
Influence of the substituents on the structure and properties of benzoxaborolesAgnieszka Adamczyk-Woźniak, Michał K Cyrański, Michał Jakubczyk, et al.
Cancers|February 11, 2023
Vemurafenib and Dabrafenib Downregulates RIPK4 LevelEwelina Madej, Anna A Brożyna, Agnieszka Adamczyk, et al.
Pageof 8